dokumendiregister.ee
Väljaminev dokumentAvalik

Vastuskiri

Terviseamet · 3. märts 2025
Viit
10.2-7/25/1389-2
Registreeritud
3. märts 2025
Dokumendi liik
Väljaminev dokument
Adressaat
Dirc Group
Saabumis/saatmisviis
vastutaja nimeliselt e-posti aadressilt välja saadetud
Funktsioon
10.2 Toodete terviseohutusega seotud toimingud
Sari
10.2-7 Tubakatooted
Toimik
10.2-7/2025
Vastutaja
Mikaela Pakosta (TA, Peadirektori asetäitja (1) vastutusvaldkond, Kemikaaliohutuse osakond)

Failid

Sisu (failidest)

Saatja: TA tpd </O=SOTSIAALMINISTEERIUM/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=8E9B10F4ECB44ECB98C97FA08C0B04F9-TA> Saaja: Rachael Perrio, Cecile Limousin Teema: Vs: Estonia - Tobacco Product Study Dear Rachael Perrio, Does your question concern the notification of a heated tobacco product device for the Estonian market? Best regards, Mikaela Pakosta Senior Specialist Department of Chemical Safety Republic of Estonia Health Board +372 794 3500 [email protected]<mailto:[email protected]> www.terviseamet.ee<http://www.terviseamet.ee> Paldiski mnt 81, 10614 Tallinn Estonia This e-mail meant for use by the person named in the letterhead. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments. Saatja: Rachael Perrio <[email protected]> Saatmisaeg: reede, 21. veebruar 2025 12:57 Adressaat: [email protected] Koopia: Cecile Limousin <[email protected]> Teema: Estonia - Tobacco Product Study Dear Estonian Health Board (Terviseamet), I am emailing to understand the submission process for a study we are looking to conduct in your country. This research study does not have an investigational medicinal product (IMP) or medical device. The investigated product is a consumer device with tobacco product. The study is evaluating cigarettes against this tobacco heating system in patients with COPD. Can I confirm if this type of study would require submission to you? If yes, please can you provide details on how this type of submission would occur? Many thanks for your input and support Best wishes, Rachael Rachael Perrio Senior Regulatory Executive Upcoming Leave: 28th February www.dlrc.co.uk<http://www.dlrc.co.uk/> Tel: +44 (0)1462 372472 Mobile: +44 (0)7563 028913 [A blue square with white letters Description automatically generated]<https://www.linkedin.com/company/dlrcgroup/> [cid:[email protected]] [cid:[email protected]]<https://www.dlrcgroup.com/dlrc-newsletter/> The information transmitted in this message is intended only for the person or entity it is addressed to and may contain confidential and/or privileged material. Any review, retransmission, dissemination or otherwise of, or taking of any action in reliance upon, this information by person or persons or entities other than the intended recipient is prohibited. If you receive it in error, please contact the sender and delete the material from any computer. Global Offices: UK | Germany | US. Company Information & Legal Notices.<https://www.dlrcgroup.com/dlrc-group-company-information-legal-notices/>
Allikas: Terviseamet dokumendiregister →